Medpace Holdings, Inc. operates as a full-service clinical research organization, supporting the clinical development process from Phase I to Phase IV across various therapeutic areas. The company's core offerings include clinical trial management, regulatory affairs, data management, and pharmacovigilance. In addition to its core CRO services, Medpace provides ancillary support through its global central laboratories, bioanalytical laboratories, and imaging core laboratories. With operations spanning North America, Europe, and Asia, the company focuses on accelerating the development of therapeutics for its specialized client base.
